ERBB2 and cholangiocarcinoma: The most common primary tumor types were cholangiocarcinoma (n = 14; 29.2%) and HER2-negative breast cancer (n = 9; 18.8%), including 6 patients with TNBC and 3 patients with HR-positive/HER2-negative breast cancer.